Document is current
Any future updates will be listed below
-
Authors
Jonkergouw, Christopher https://orcid.org/0000-0001-9445-9864
Beyeh, Ngong Kodiah https://orcid.org/0000-0003-3935-1812
Osmekhina, Ekaterina https://orcid.org/0000-0002-5756-9877
Leskinen, Katarzyna
Taimoory, S. Maryamdokht
Fedorov, Dmitrii
Anaya-Plaza, Eduardo https://orcid.org/0000-0001-9944-6907
Kostiainen, Mauri A. https://orcid.org/0000-0002-8282-2379
Trant, John F. https://orcid.org/0000-0002-4780-4968
Ras, Robin H. A. https://orcid.org/0000-0002-2076-242X
Saavalainen, Päivi
Linder, Markus B. https://orcid.org/0000-0002-7271-6441
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (2018-06338)
Academy of Finland (346105)
- License Information
-
More Information
Article History
Received: 15 August 2022
Accepted: 29 March 2023
First Online: 14 April 2023
Competing interests
: Aalto University together with the University of Helsinki has filed for patent applications FI20185841A1, FI20205369A1 and FI20205368A1 on the effects of macrocycles on Gram-negative pathogens, with C.J., N.K.B., E.O., K.L., R.H.A.R., P.S. and M.B.L as co-inventors. C.J., E.O. and K.L. are co-founders of Arivin therapeutics Oy. The funders had no influence on the design or collection of results, interpretation of the data or writing of the manuscript. The remaining authors declare no other competing interests.
